4-amino-2-methyl-6-methylaminoquinoline | 321534-78-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-amino-2-methyl-6-methylaminoquinoline
• 英文别名: N',2-dimethylquinoline-4,6-diamine；6-N,2-dimethylquinoline-4,6-diamine
• CAS: 321534-78-5
• 化学式: C₁₁H₁₃N₃
• 分子量: 187.244
• InChiKey: UUMZBBNMERQWCK-UHFFFAOYSA-N

物化性质

• 沸点：
  403.2±40.0 °C(Predicted)
• 密度：
  1.209±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  50.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-amino-2-methyl-6-methylaminoquinoline 、 2-(4-chlorophenoxymethyl)-benzoyl chloride 在 吡啶 作用下， 反应 16.0h， 生成 N-(4-Amino-2-methyl-quinolin-6-yl)-2-(4-chloro-phenoxymethyl)-N-methyl-benzamide
  参考文献：
  名称：

  4-Aminoquinolines:  Novel Nociceptin Antagonists with Analgesic Activity

  摘要：

  Small-molecule nociceptin antagonists were synthesized to examine their therapeutic potential. After a 4-aminoquinoline derivative was found to bind with the human ORL1 receptor, a series of 4-aminoquinolines and related compounds were synthesized and their binding was evaluated. Elucidation of structure-activity relationships eventually led to the optimum compounds. One of the se compounds, N-(4-amino-2-methylquinolin-6-yl) -2-(4-ethylphenoxymethyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced allodynia in mice but also showed analgesic effect in a hot plate test using mice and in a formalin test using rats. Its analgesic effect was not antagonized by the opioid antagonist naloxone. These results indicate that this nociceptin antagonist has the potential to become a novel type of analgesic that differs from mu -opioid agonists.

  DOI：

  10.1021/jm0002073
• 作为产物：
  描述：

  4′-氨基乙酰苯胺 在 盐酸 、 ammonium acetate 、 sodium hydride 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 49.17h， 生成 4-amino-2-methyl-6-methylaminoquinoline
  参考文献：
  名称：

  4-Aminoquinolines:  Novel Nociceptin Antagonists with Analgesic Activity

  摘要：

  Small-molecule nociceptin antagonists were synthesized to examine their therapeutic potential. After a 4-aminoquinoline derivative was found to bind with the human ORL1 receptor, a series of 4-aminoquinolines and related compounds were synthesized and their binding was evaluated. Elucidation of structure-activity relationships eventually led to the optimum compounds. One of the se compounds, N-(4-amino-2-methylquinolin-6-yl) -2-(4-ethylphenoxymethyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced allodynia in mice but also showed analgesic effect in a hot plate test using mice and in a formalin test using rats. Its analgesic effect was not antagonized by the opioid antagonist naloxone. These results indicate that this nociceptin antagonist has the potential to become a novel type of analgesic that differs from mu -opioid agonists.

  DOI：

  10.1021/jm0002073

文献信息

• N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN
  申请人：Chapdelaine Marc

  公开号：US20070129363A1

  公开（公告）日：2007-06-07

  Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R 1 , R 2 and R 3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
• US7189714B2
  申请人：——

  公开号：US7189714B2

  公开（公告）日：2007-03-13
• US7348340B2
  申请人：——

  公开号：US7348340B2

  公开（公告）日：2008-03-25
• 4-Aminoquinolines:  Novel Nociceptin Antagonists with Analgesic Activity
  作者：Hisashi Shinkai、Takao Ito、Tetsuya Iida、Yuki Kitao、Hideki Yamada、Itsuo Uchida

  DOI：10.1021/jm0002073

  日期：2000.11.1

  Small-molecule nociceptin antagonists were synthesized to examine their therapeutic potential. After a 4-aminoquinoline derivative was found to bind with the human ORL1 receptor, a series of 4-aminoquinolines and related compounds were synthesized and their binding was evaluated. Elucidation of structure-activity relationships eventually led to the optimum compounds. One of the se compounds, N-(4-amino-2-methylquinolin-6-yl) -2-(4-ethylphenoxymethyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced allodynia in mice but also showed analgesic effect in a hot plate test using mice and in a formalin test using rats. Its analgesic effect was not antagonized by the opioid antagonist naloxone. These results indicate that this nociceptin antagonist has the potential to become a novel type of analgesic that differs from mu -opioid agonists.